You are here

YM BioSciences

8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers

Seeking Alpha

Mon, 10/3/11 - 12:37 pm

Aeterna Zentaris

BioDelivery Sciences

Human Genome Sciences

Peregrine Pharmaceuticals

SIGA technologies

The Big Bet on YM BioSciences

Motley Fool

Thu, 09/1/11 - 12:14 pm

YM BioSciences JAK Inhibitor CYT387 Shown Active in Multiple Myeloma

Yahoo

Thu, 08/4/11 - 10:56 am

Multiple Myeloma

Should Biotech Investors Go Where Institutions Won't?

Investopedia

Thu, 07/7/11 - 12:04 pm

Aeterna Zentaris

Seattle Genetics

10 Biotech Trades for Second Half of 2011

TheStreet.com

Wed, 07/6/11 - 08:51 am

Sangamo BioSciences

Seattle Genetics

Gilead Sciences

Exelixis, YM Biosciences Lead Losers at Cancer Meeting

Minyanville

Sat, 06/11/11 - 10:22 am

A Dull ASCO And The Usual Sell-Off

Investopedia

Tue, 06/7/11 - 07:34 pm

Bristol-Myers Squibb

5 Biotechs With Upcoming Clinical Trial Results

Motley Fool

Wed, 06/1/11 - 07:52 am

Gilead Sciences

Incyte and YM Biosciences in Race to Market Strongest JAK Inhibitor

Seeking Alpha

Thu, 04/21/11 - 11:46 am

4 Biotech Penny Stocks to Buy: Navellier

TheStreet.com

Thu, 04/14/11 - 10:59 am

Aeterna Zentaris

YM Biosciences' Worrisome Business Model

Seeking Alpha

Mon, 03/28/11 - 11:42 am

Biotech Mailbag: BIO CEO Wrap

TheStreet.com

Fri, 02/18/11 - 09:36 am

BIO CEO Conference

Teva Pharmaceuticals

Cell Therapeutics

BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011

Seeking Alpha

Tue, 12/28/10 - 11:58 am

The Winner of ASH 2010: Seattle Genetics

Seeking Alpha

Mon, 12/20/10 - 09:59 am

Seattle Genetics

Ym Biosciences Prices $40 Million Public Offering

Yahoo

Tue, 12/14/10 - 11:07 am

Virgin Market for New Bone Marrow Cancer Drug

Minyanville

Sat, 11/27/10 - 12:32 pm

ONYX Pharmaceuticals

YM BioSciences inks deal to acquire Cytopia

Fierce Biotech

Tue, 10/6/09 - 11:21 am

Pages